692
V. L. Rendina et al.
PRACTICAL SYNTHETIC PROCEDURES
1H NMR (CDCl3, 400 MHz): d = 7.54–7.48 (m, 2 H), 7.34–7.28 (m,
1 H), 7.12–7.05 (m, 1 H), 4.67 (dd, J = 11.5, 3.3 Hz, 1 H), 2.74
(ddd, J = 14.9, 7.4, 3.1 Hz, 1 H), 2.49–2.40 (m, 1 H), 2.39–2.25 (m,
1 H), 2.15–2.04 (m, 1 H), 2.03–1.88 (m, 2 H), 1.86–1.66 (m, 3 H),
1.65–1.52 (m, 2 H), 1.37–1.24 (m, 1 H).
1.4 equiv). The crude reaction mixture was directly purified by col-
umn chromatography to afford 4i as a colorless oil (31.3 mg, 97%
yield) with 93.5:6.5 er [AS-H, 50 °C, 150 psi, 2.5 mL/min, 2%
MeOH, l = 220 nm; tR = 2.74 min (minor), 3.11 min (major)];
[a]D20 –98.1 (c 1.26, CHCl3); Rf = 0.21 (10% EtOAc in hexanes).
13C NMR (100 MHz, CDCl3): d = 215.99, 139.78, 132.55, 130.04,
128.33, 127.68, 124.54, 52.89, 44.67, 35.56, 28.61, 25.74, 25.08,
23.87.
IR (neat): 3096 (w), 3020 (w), 2927 (br s), 2856 (w), 1697 (s), 1488
(w), 1464 (m), 1446 (m), 1325 (m), 1160 (w), 1123 (w), 845 (w),
755 (br m), 730 cm–1 (m).
HRMS (ESI+): m/z calcd for C14H18BrO [M + H]+: 281.0541;
found: 281.0571.
1H NMR (CDCl3, 400 MHz): d = 7.45–7.41 (m, 1 H), 7.23–7.17 (m,
1 H), 7.16–7.10 (m, 2 H), 4.06 (dd, J = 12.1, 2.7 Hz, 1 H), 2.72
(ddd, J = 13.1, 11.7, 4.3 Hz, 1 H), 2.46–2.35 (m, 1 H), 2.40 (s, 3 H),
2.33–2.23 (m, 1 H), 2.01–1.87 (m, 3 H), 1.84–1.71 (m, 2 H), 1.67–
1.46 (m, 4 H).
13C NMR (100 MHz, CDCl3): d = 216.22, 138.06, 136.47, 130.63,
127.04, 126.83, 126.33, 53.04, 40.77, 32.02, 27.21, 27.15, 27.04,
24.91, 20.21.
(S)-2-(4-Trifluromethylphenyl)cyclooctanone (4g)
Run for 14 h at –78 °C according to the general procedure with
Sc(OTf)3 (7.4 mg, 0.015 mmol, 10 mol%), ligand 6 (8.5 mg, 0.016
mmol, 11 mol%), toluene (1.5 mL), cycloheptanone (18 mL, 0.15
mmol, 1.0 equiv), and 2d (320 mL, 0.21 mmol, 0.66 M in toluene,
1.4 equiv). The crude reaction mixture was directly purified by col-
umn chromatography to afford 4g as a colorless oil (31.7 mg, 78%)
with 98:2 er [AD-H, 50 °C, 150 psi, 1.0 mL/min, 3%
MeOH, l = 220 nm; tR = 8.69 min (minor), 9.44 min (major)];
[a]D20 –93.52 (c 0.88, CHCl3); Rf = 0.18 (10% EtOAc in hexanes).
HRMS (ESI+): m/z calcd for C15H21O [M + H]+: 217.1591; found:
217.1592.
(S)-2-(4-Methylphenyl)cyclooctanone (4j)
Run for 3 h at –78 °C according to the general procedure with
Sc(OTf)3 (7.4 mg, 0.015 mmol, 10 mol%), ligand 6 (8.5 mg, 0.016
mmol, 11 mol%), toluene (1.5 mL), cycloheptanone (18 mL, 0.15
mmol, 1.0 equiv), and 2h (320 mL, 0.21 mmol, 0.66 M in toluene,
1.4 equiv). The crude reaction mixture was directly purified by col-
umn chromatography to afford 4j as a colorless oil (32.5 mg, quant)
with 98.5:1.5 er [AS-H, 50 °C, 150 psi, 3.0 mL/min, 4%
MeOH, l = 220 nm; tR = 1.90 min (minor), 2.13 min (major)];
[a]D20 –148.9 (c 0.98, CHCl3); Rf = 0.37(10% EtOAc in hexanes).
IR (neat): 2935 (br w), 2860 (br w), 1703 (m), 1617 (w), 1466 (w),
1447 (w), 1419 (w), 1325 (s), 1163 (m), 1122 (m), 1069 (m), 1019
(m), 838 cm–1 (br w).
1H NMR (CDCl3, 400 MHz): d = 7.56 (d, J = 8.0 Hz, 1 H), 7.46
(d, J = 8.0 Hz, 1 H), 3.92 (dd, J = 12.1, 2.9 Hz, 1 H), 2.55
(ddd, J = 12.5, 12.5, 3.7 Hz, 1 H), 2.38–2.22 (m, 2 H), 2.10–1.97
(m, 2 H), 1.96–1.86 (m, 1 H), 1.84–1.69 (m, 2 H), 1.64–1.46 (m, 4
H).
13C NMR (100 MHz, CDCl3): d = 215.72, 143.67 (q, JC,F = 1.5 Hz),
129.40 (q, JC,F = 32.2 Hz), 128.44, 125.50 (q, JC,F = 3.7 Hz), 124.30
(q, JC,F = 271.5 Hz), 56.73, 41.40, 32.97, 27.22, 26.44, 26.18, 24.75.
HRMS (ESI+): m/z calcd for C15H18F3O [M + H]+: 271.1310; found:
271.1341.
IR (neat): 3021 (br w), 2926 (br s), 2856 (br m), 1698 (s), 1513 (m),
1465 (w), 1446 (w), 1159 (w), 818 cm–1 (m).
1H NMR (CDCl3, 400 MHz): d = 7.22 (d, J = 8.2 Hz, 2 H), 7.11
(d, J = 8.0 Hz, 2 H), 3.74 (dd, J = 12.3, 2.7 Hz, 1 H), 2.61
(ddd, J = 12.7, 11.7, 4.5 Hz, 1 H), 2.42–2.29 (m, 1 H), 2.31 (s, 3 H),
2.26–2.20 (m, 1 H), 2.00–1.85 (m, 3 H), 1.81–1.70 (m, 2 H), 1.63–
1.54 (m, 2 H), 1.53–1.36 (m, 2 H).
(S)-2-(3-Methoxyphenyl)cyclooctanone (4h)
Run for 3 h at –78 °C according to the general procedure with
Sc(OTf)3 (7.4 mg, 0.015 mmol, 10 mol%), ligand 6 (8.5 mg, 0.016
mmol, 11 mol%), toluene (1.5 mL), cycloheptanone (18 mL, 0.15
mmol, 1.0 equiv), and 2e (200 mL, 0.21 mmol, 1.05 M in toluene,
1.4 equiv). The crude reaction mixture was directly purified by col-
umn chromatography to afford 4h as a colorless oil (35.1 mg, quant)
with 97:3 er [AS-H, 50 °C, 150 psi, 2.0 mL/min, 2%
MeOH, l = 220 nm; tR = 2.05 min (minor), 2.26 min (major)];
[a]D20 –116.3 (c 0.99, CHCl3); Rf = 0.16 (10% EtOAc in hexanes).
13C NMR (100 MHz, CDCl3): d = 216.75, 136.78, 136.44, 129.37,
127.76, 57.26, 40.16, 31.46, 27.13, 26.92, 26.82, 24.78, 21.13.
HRMS (ESI+): m/z calcd for C15H21O [M + H]+: 217.1592; found:
217.1599.
(S)-2-(Napthalen-1-yl)cyclooctanone (4k)
Run for 14 h at –78 °C according to the general procedure with
Sc(OTf)3 (7.4 mg, 0.015 mmol, 10 mol%), ligand 5 (5.9 mg, 0.016
mmol, 11 mol%), toluene (1.5 mL), cycloheptanone (18 mL, 0.15
mmol, 1.0 equiv), and 2g (396 mL, 0.21 mmol, 0.53 M in toluene,
1.4 equiv). The crude reaction mixture was directly purified by col-
umn chromatography to afford 4k as a pale yellow solid (35.5 mg,
94%) with 93:7 er [AD-H, 50 °C, 150 psi, 2.0 mL/min, 3%
MeOH, l = 220 nm; tR = 21.52 min (major), 25.15 min (minor)];
mp 97–100 °C; [a]D20 +48.3 (c 0.82, CHCl3); Rf = 0.20 (10%
EtOAc in hexanes).
IR (neat): 2929 (s), 2856 (w), 1697 (s), 1598 (m), 1583 (m), 1491
(m), 1465 (m), 1286 (s), 1048 (m), 767 (w), 696 cm–1 (w).
1H NMR (CDCl3, 400 MHz): d = 7.24–7.18 (m, 1 H), 6.94–6.88 (m,
2 H), 6.80–6.75 (m, 1 H), 3.80 (s, 3 H), 3.75 (dd, J = 12.5, 2.7 Hz,
1 H), 2.62 (ddd, J = 11.7, 4.7 Hz, 1 H), 2.41–2.29 (m, 1 H), 2.29–
2.21 (m, 1 H), 2.03–1.84 (m, 3 H), 1.82–1.69 (m, 2 H), 1.64–1.53
(m, 2 H), 1.53–1.34 (m, 2 H).
13C NMR (100 MHz, CDCl3): d = 216.41, 159.79, 140.98, 129.53,
120.21, 113.81, 112.41, 57.60, 55.31, 40.25, 31.44, 27.10, 26.87,
26.80, 24.74.
HRMS (ESI+): m/z calcd for C15H21O2 [M + H]+: 233.1542; found:
233.1560.
IR (neat): 3042 (w), 2924 (br m), 2898 (br w), 1689 (s), 1510 (w),
1397 (w), 1117 (m), 800 (m), 780 cm–1 (br s).
1H NMR (CDCl3, 400 MHz): d = 8.33–8.28 (m, 1 H), 7.87–7.83 (m,
1 H), 7.79–7.74 (m, 1 H), 7.64–7.60 (m, 1 H), 7.60–7.54 (m, 1 H),
7.51–7.45 (m, 2 H), 4.65 (dd, J = 12.1, 2.6 Hz, 1 H), 2.82
(ddd, J = 12.3, 12.3, 3.9 Hz, 1 H), 2.68–2.55 (m, 1 H), 2.30
(ddd, J = 12.9, 5.7, 3.7 Hz, 1 H), 2.11–1.94 (m, 3 H), 1.90–1.79 (m,
2 H), 1.78–1.63 (m, 2 H), 1.61–1.49 (m, 2 H).
13C NMR (100 MHz, CDCl3): d = 215.91, 135.62, 134.07, 131.86,
129.01, 127.75, 126.46, 125.70, 125.59, 124.63, 123.68, 52.49,
39.88, 31.66, 27.41, 27.30, 26.91, 24.92.
(S)-2-(2-Methylphenyl)cyclooctanone (4i)
Run for 14 h at –78 °C according to the general procedure with
Sc(OTf)3 (7.4 mg, 0.015 mmol, 10 mol%), ligand 5 (5.9 mg, 0.016
mmol, 11 mol%), toluene (1.5 mL), cycloheptanone (18 mL, 0.15
mmol, 1.0 equiv), and 2f (180 mL, 0.21 mmol, 1.18 M in toluene,
Synthesis 2012, 44, 686–693
© Thieme Stuttgart · New York